Groupama Asset Management’s AbbVie ABBV Stock Holding History

Groupama Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.7M	Buy	183,915 +27,765	+18%	+$5.97M	0.59%	43
2026 Q1	$34M	Sell	156,150 -3,644	-2%	-$808K	0.5%	49
2025 Q4	$36.5M	Sell	159,794 -747	-0.5%	-$170K	0.53%	44
2025 Q3	$37.2M	Buy	160,541 +10,854	+7%	+$2.21M	0.54%	43
2025 Q2	$27.3M	Buy	149,687 +2,290	+2%	+$426K	0.45%	47
2025 Q1	$30.3M	Buy	147,397 +17,290	+13%	+$3.36M	0.6%	42
2024 Q4	$22.9M	Sell	130,107 -5,642	-4%	-$1.04M	0.47%	49
2024 Q3	$21.5M	Buy	135,749 +38,974	+40%	+$7.27M	0.56%	44
2024 Q2	$16.6M	Buy	96,775 +12,822	+15%	+$2.12M	0.23%	75
2024 Q1	$15.6M	Sell	83,953 -3,600	-4%	-$620K	0.28%	70
2023 Q4	$13.6M	Buy	+87,553	New	+$12.8M	0.35%	55

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Groupama Asset Management's ABBV Position: Q2 2026 in Review

Groupama Asset Management increased its AbbVie (ABBV) stake by 18% in Q2 2026, buying an estimated $5.97M and bringing the position to 183,915 shares worth $46.7M. The position accounts for 0.59% of the portfolio, ranked #43.

Groupama Asset Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Groupama Asset Management held 183,915 shares of AbbVie worth $46.7M as of Q2 2026.
Groupama Asset Management bought 27,765 AbbVie shares in Q2 2026, an estimated $5.97M.
AbbVie made up 0.59% of Groupama Asset Management's portfolio in Q2 2026, its #43 holding.
Groupama Asset Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.